Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Analysis of the Protective Immunity Induced by Herpes Simplex Virus 1 Strain M3 with an Attenuated Phenotype Due to Mutations in the Viral ul7, ul41, and LAT Genes.

Xu X, Fan S, Wang X, Hu Y, Feng M, Wang L, Zhang Y, Liao Y, Zhang X, Li Q.

Front Microbiol. 2017 Oct 9;8:1958. doi: 10.3389/fmicb.2017.01958. eCollection 2017.

2.

Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

De Paschale M, Clerici P.

World J Virol. 2016 Aug 12;5(3):97-124. doi: 10.5501/wjv.v5.i3.97. Review.

3.

Efficacy of varicella (VZV) vaccination: an update for the clinician.

Wang L, Zhu L, Zhu H.

Ther Adv Vaccines. 2016 Jan;4(1-2):20-31. doi: 10.1177/2051013616655980. Epub 2016 Jan 1.

4.

Chickenpox Appearing in Previously Vaccinated Individuals.

Suryam V, Das AL.

Med J Armed Forces India. 2009 Jul;65(3):280-1. doi: 10.1016/S0377-1237(09)80028-2. Epub 2011 Jul 21. No abstract available.

5.

Two-dose varicella vaccine effectiveness and rash severity in outbreaks of varicella among public school students.

Thomas CA, Shwe T, Bixler D, del Rosario M, Grytdal S, Wang C, Haddy LE, Bialek SR.

Pediatr Infect Dis J. 2014 Nov;33(11):1164-8. doi: 10.1097/INF.0000000000000444.

6.

Evaluation of a commercial glycoprotein enzyme-linked immunosorbent assay for measuring vaccine immunity to varicella.

Kim YH, Hwang JY, Shim HM, Lee E, Park S, Park H.

Yonsei Med J. 2014 Mar;55(2):459-66. doi: 10.3349/ymj.2014.55.2.459.

7.

Primary versus secondary failure after varicella vaccination: implications for interval between 2 doses.

Bonanni P, Gershon A, Gershon M, Kulcsár A, Papaevangelou V, Rentier B, Sadzot-Delvaux C, Usonis V, Vesikari T, Weil-Olivier C, de Winter P, Wutzler P.

Pediatr Infect Dis J. 2013 Jul;32(7):e305-13. doi: 10.1097/INF.0b013e31828b7def. Review.

8.

Correlates of protection induced by vaccination.

Plotkin SA.

Clin Vaccine Immunol. 2010 Jul;17(7):1055-65. doi: 10.1128/CVI.00131-10. Epub 2010 May 12. Review.

9.

Impact of varicella vaccine on varicella-zoster virus dynamics.

Schmid DS, Jumaan AO.

Clin Microbiol Rev. 2010 Jan;23(1):202-17. doi: 10.1128/CMR.00031-09. Review.

10.

Canada's first universal varicella immunization program: Lessons from Prince Edward Island.

Sweet L, Gallant P, Morris M, Halperin SA.

Can J Infect Dis. 2003 Jan;14(1):41-4.

11.

Three-year follow-up of protection rates in children given varicella vaccine.

Scheifele DW, Halperin SA, Diaz-Mitoma F.

Can J Infect Dis. 2002 Nov;13(6):382-6.

12.

Deterministic SIR (Susceptible-Infected-Removed) models applied to varicella outbreaks.

Giraldo JO, Palacio DH.

Epidemiol Infect. 2008 May;136(5):679-87. Epub 2007 Jul 26.

13.

Preventing varicella-zoster disease.

Hambleton S, Gershon AA.

Clin Microbiol Rev. 2005 Jan;18(1):70-80. Review.

14.

Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T cell response to the SIV envelope protein.

Staprans SI, Barry AP, Silvestri G, Safrit JT, Kozyr N, Sumpter B, Nguyen H, McClure H, Montefiori D, Cohen JI, Feinberg MB.

Proc Natl Acad Sci U S A. 2004 Aug 31;101(35):13026-31. Epub 2004 Aug 23.

15.

Necrotizing fasciitis secondary to chickenpox infection in children.

Clark P, Davidson D, Letts M, Lawton L, Jawadi A.

Can J Surg. 2003 Feb;46(1):9-14.

16.

Active immunization in the United States: developments over the past decade.

Dennehy PH.

Clin Microbiol Rev. 2001 Oct;14(4):872-908, table of contents. Review.

17.

Varicella vaccination--a critical review of the evidence.

Skull SA, Wang EE.

Arch Dis Child. 2001 Aug;85(2):83-90. Review. No abstract available.

18.

Varicella: to vaccinate or not to vaccinate?

Gershon A.

Arch Dis Child. 1998 Dec;79(6):470-1. No abstract available.

Supplemental Content

Support Center